BOLD - Audentes Therapeutics misses by $0.24 May, 07 2019 04:17 PM Audentes Therapeutics Inc. Audentes Therapeutics (NASDAQ:BOLD): Q1 GAAP EPS of -$1.13 misses by $0.24.Cash and equivalents of $378.8M.Press ReleaseMore news on: Audentes Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,